company background image
PAX logo

Paxman OM:PAX Stock Report

Last Price

kr36.30

Market Cap

kr690.2m

7D

5.2%

1Y

8.4%

Updated

27 Mar, 2024

Data

Company Financials +

PAX Stock Overview

Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide.

PAX fundamental analysis
Snowflake Score
Valuation2/6
Future Growth6/6
Past Performance3/6
Financial Health5/6
Dividends0/6

Paxman AB (publ) Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Paxman
Historical stock prices
Current Share Pricekr36.30
52 Week Highkr39.70
52 Week Lowkr22.00
Beta0.72
1 Month Change-2.16%
3 Month Change0%
1 Year Change8.36%
3 Year Change-27.40%
5 Year Change-18.79%
Change since IPO233.03%

Recent News & Updates

Does Paxman (STO:PAX) Have A Healthy Balance Sheet?

Dec 23
Does Paxman (STO:PAX) Have A Healthy Balance Sheet?

Paxman (STO:PAX) Shareholders Will Want The ROCE Trajectory To Continue

Aug 25
Paxman (STO:PAX) Shareholders Will Want The ROCE Trajectory To Continue

Recent updates

Does Paxman (STO:PAX) Have A Healthy Balance Sheet?

Dec 23
Does Paxman (STO:PAX) Have A Healthy Balance Sheet?

Paxman (STO:PAX) Shareholders Will Want The ROCE Trajectory To Continue

Aug 25
Paxman (STO:PAX) Shareholders Will Want The ROCE Trajectory To Continue

Paxman AB (publ) (STO:PAX) Could Be Riskier Than It Looks

Jun 01
Paxman AB (publ) (STO:PAX) Could Be Riskier Than It Looks

Does Paxman (STO:PAX) Have A Healthy Balance Sheet?

Nov 20
Does Paxman (STO:PAX) Have A Healthy Balance Sheet?

Is Paxman (STO:PAX) A Risky Investment?

Mar 07
Is Paxman (STO:PAX) A Risky Investment?

Paxman (STO:PAX) Is Making Moderate Use Of Debt

Mar 15
Paxman (STO:PAX) Is Making Moderate Use Of Debt

Are Insiders Buying Paxman AB (publ) (STO:PAX) Stock?

Jan 22
Are Insiders Buying Paxman AB (publ) (STO:PAX) Stock?

Reflecting on Paxman's (STO:PAX) Share Price Returns Over The Last Year

Dec 18
Reflecting on Paxman's (STO:PAX) Share Price Returns Over The Last Year

Shareholder Returns

PAXSE Medical EquipmentSE Market
7D5.2%0.5%1.8%
1Y8.4%-3.9%19.0%

Return vs Industry: PAX exceeded the Swedish Medical Equipment industry which returned -3.9% over the past year.

Return vs Market: PAX underperformed the Swedish Market which returned 19% over the past year.

Price Volatility

Is PAX's price volatile compared to industry and market?
PAX volatility
PAX Average Weekly Movement4.2%
Medical Equipment Industry Average Movement8.1%
Market Average Movement6.0%
10% most volatile stocks in SE Market12.7%
10% least volatile stocks in SE Market3.4%

Stable Share Price: PAX has not had significant price volatility in the past 3 months.

Volatility Over Time: PAX's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199691Richard Paxmanhttps://paxmanscalpcooling.com

Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide. It serves various clinics and treatment centers, and hospitals. The company has a research collaboration agreement with National University Hospital, Singapore for the development of portable cooling and compression device.

Paxman AB (publ) Fundamentals Summary

How do Paxman's earnings and revenue compare to its market cap?
PAX fundamental statistics
Market capkr690.15m
Earnings (TTM)kr8.24m
Revenue (TTM)kr220.61m

83.8x

P/E Ratio

3.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PAX income statement (TTM)
Revenuekr220.61m
Cost of Revenuekr74.19m
Gross Profitkr146.42m
Other Expenseskr138.18m
Earningskr8.24m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Apr 26, 2024

Earnings per share (EPS)0.43
Gross Margin66.37%
Net Profit Margin3.73%
Debt/Equity Ratio11.1%

How did PAX perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.